Italia markets closed

BMY Sep 2024 62.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
11,300,00 (0,00%)
Alla chiusura: 10:30AM EDT
Schermo intero
Chiusura precedente11,30
Aperto11,30
Denaro17,15
Lettera19,05
Prezzo d'esercizio62,50
Scadenza2024-09-20
Min-Max giorno11,30 - 11,30
Contratto - Min-MaxN/D
Volume1
Open Interest12
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri